- Latest available (Revised)
- Original (As adopted by EU)
2000/428/EC: Commission Decision of 4 July 2000 establishing diagnostic procedures, sampling methods and criteria for the evaluation of the results of laboratory tests for the confirmation and differential diagnosis of swine vesicular disease (notified under document number C(2000) 1805) (Text with EEA relevance)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
There are currently no known outstanding effects by UK legislation for 2000/428/EC: Commission Decision, CHAPTER I.![]()
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
provides for guidelines and minimum requirements on diagnostic procedures, sampling methods and criteria for the evaluation of the results of laboratory tests for a proper diagnosis of swine vesicular disease. However, particular emphasis is also on the differential diagnosis with foot-and-mouth disease;
integrates the provisions of Annex II to Directive 92/119/EEC, and in particular of paragraphs 4, 7 and 8 of the said Annex;
is principally directed towards the authorities responsible for the control of swine vesicular disease.
Therefore, emphasis is on the principles and applications of laboratory tests and evaluation of their results and not on detailed laboratory techniques.
"seropositive pig" means any pig whose serum has an antibody titre equal to or greater than the swine vesicular disease Reference Serum 4 referred to in Chapter X in the virus neutralisation test used by the National Laboratory;
"singleton reactor" means any single seropositive pig in a holding which yields a positive result in serological tests for swine vesicular disease, but which has no history of contact with swine vesicular disease virus and from which there is no evidence of spread of infection to in-contact pigs. A seropositive pig is confirmed to be a singleton reactor if the conditions referred to in Chapter VIII(C) are fulfilled;
"in-contact pigs" means the pigs which have direct contact, or have had direct contact within the last 28 days, with one or more seropositive pigs or with one or more pigs suspected to be infected with swine vesicular disease virus. In-contact pigs may be, or may have been, in the same pen or in adjacent pens if there is the possibility of pig-to-pig contact between pens.
those set out in this Manual; or
those authorised by the Secretary of State, provided that—
the sensitivity and specificity of the authorised laboratory test has been demonstrated as being effective following a comparative test; or
where no such evaluation has been organised for a specific type of laboratory test, the sensitivity and specificity of the authorised laboratory test have been validated by the national reference laboratory so that the laboratory test is fit for the purposes for which it is used.]
Textual Amendments
F1Annex Ch. 1 para. 3 inserted (E.W.) (29.4.2026) by The Exotic Animal Disease (Amendment) (England) Order 2026 (S.I. 2026/475), arts. 1(1), 4(1)(2)(a)
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: